Healthcare Industry News: proximal humerus
News Release - December 13, 2013
The Orthopaedic Implant Company Releases High Value Proximal Humerus PlateRENO, Nev.--(Healthcare Sales & Marketing Network)--The Orthopaedic Implant Company (“OIC”) released its proximal humerus Plate today, completing its high value solution for upper extremity fractures. The plate’s design addresses two key challenges specific to proximal humerus fractures; prevention of subacromial impingement and varus collapse of the humeral head. Additionally, suture holes allow surgeons to place sutures addressing tuberosity repairs post humeral-head fixation.
OIC’s proximal humerus, Distal Radius and Clavicle Plates are supported by a single set of instrumentation and screws. The modularity of the set reinforces physicians’ familiarity and comfort with the instrumentation, while providing facilities with a simple approach to set management for a broad spectrum of cases.
The system provides lag screw fixation for comminuted patterns, non-locking screws to obtain compression across simple patterns and locking fixation in osteopenic bone and multi-fragmentary fracture patterns.
“The response to our high value upper extremity plates has been overwhelmingly positive,” says Itai Nemovicher, OIC President and CEO. “We are proud to offer our customers the ability to now save on proximal humerus plates as well.”
The OIC Anatomic Locking Plate and Screw Line will continually expand in the coming months.
For more information about The Orthopaedic Implant Company please visit www.orthoimplantcompany.com
About Orthopaedic Implant Company
OIC entered the medical device market in 2010 with an innovative approach to delivering the highest quality implants at the lowest possible price. OIC implants cost 50 to 60 percent less than the average market price of premium implants, saving health care systems millions of dollars a year. OIC’s high-quality, low-cost implants and products can be used for a variety of procedures, including treatment of orthopaedic trauma and spinal injuries. All OIC products are FDA approved and manufactured in FDA approved facilities.
Source: The Orthopaedic Implant Company
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.